Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A single arm, open-label phase II is appropriate to evaluate the efficacy and safety of dose
- dense combination of paclitaxel with cisplatin supported by pegfilgrastim for neo-adjuvant
chemotherapy in this patient population.